Navigation Links
ADVENTRX Pharmaceuticals Receives PDUFA Date for Exelbine™ NDA
Date:1/19/2011

tential for the FDA to impose other requirements to be completed before or after approval of the Exelbine NDA, including that the FDA may require ADVENTRX to perform additional nonclinical, bioequivalence or clinical studies; ADVENTRX's reliance on third parties to assist with its bioequivalence trials, regulatory submissions, manufacturing and other important aspects of the Exelbine development program, and the risk that FDA approval may be delayed if their performance is found to have been substandard; the risk that any patent issued to ADVENTRX may not provide sufficient protection and market exclusivity for Exelbine and may be challenged, invalidated, infringed or circumvented by third parties, including by ADVENTRX's competitors; ADVENTRX's dependence on the success of Exelbine as its first product candidate to be submitted for regulatory approval; the potential that ADVENTRX may require substantial additional funding to obtain FDA approval for and commercialize Exelbine, and the risks inherent in these activities; the potential for ADVENTRX to enter into a commercial partnership or other strategic transaction relating to Exelbine and that such partnership or transaction may not succeed in commercializing Exelbine; and other risks and uncertainties more fully described in ADVENTRX's press releases and periodic filings with the Securities and Exchange Commission. ADVENTRX's public filings with the Securities and Exchange Commission are available at www.sec.gov.  

You are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date when made. ADVENTRX does not intend to revise or update any forward-looking statement set forth in this press release to reflect events or circumstances arising after the date hereof, except as may be required by law.


'/>"/>
SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
2. ADVENTRX Announces Completion of Patient Enrollment in ANX-530 Marketing-Enabling Clinical Study
3. ADVENTRX Meets Primary Endpoint in ANX-530 Marketing-Enabling Clinical Study
4. ADVENTRX Announces Completion of Patient Enrollment in Phase 2 Clinical Trial of CoFactor(R) for the Treatment of Advanced Breast Cancer
5. ADVENTRX to Present ANX-201 Preclinical Data at Keystone Symposia HIV Pathogenesis Conference
6. ADVENTRX to Present CoFactor Phase 2 Breast Cancer Data at the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO)
7. ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study
8. ADVENTRX Presents CoFactor Data at the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO)
9. ADVENTRX Announces CoFactor(R) Phase 2b Clinical Trial Overall Survival Results
10. ADVENTRX Announces Preliminary Response Rate Data From Discontinued Phase 3 Trial of CoFactor(R)
11. ADVENTRX Completes Patient Enrollment in ANX-514 Bioequivalence Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... novembre 2014  Surgical Theater LLC ha ... esposta durante l,apertura in data 24 novembre ... la Fondazione IRCCS Istituto Neurologico Nazionale "C. ... (strumento di pianificazione chirurgica) e Surgical Navigation ... avanzata) saranno presentati in occasione dell,evento dedicato ...
(Date:11/22/2014)... 22, 2014  Sprout Pharmaceuticals today announced positive preliminary results ... treated with flibanserin up to 200 mg at bedtime had ... at the 20 th Annual Fall Scientific Meeting of ... in Miami . The ... Complete Response Letter and the Formal Dispute Resolution that was ...
(Date:11/22/2014)... DENVER , Nov. 21, 2014 Statistics ... drinking and drunk driving increase astronomically during the holidays, ... Wednesday" in many cities. The data, ... Alcohol Monitoring Systems as part of their annual ... paints a picture of high-risk drinking and increased ...
Breaking Medicine Technology:La tecnologia di Surgical Theater in mostra in Italia all'apertura del centro Besta NeuroSim di Milano 2La tecnologia di Surgical Theater in mostra in Italia all'apertura del centro Besta NeuroSim di Milano 3La tecnologia di Surgical Theater in mostra in Italia all'apertura del centro Besta NeuroSim di Milano 4Sprout Pharmaceuticals Presents Phase 1 Clinical Trial Data Showing Treatment With Flibanserin Results In No Next-Day Driving Impairment 2Sprout Pharmaceuticals Presents Phase 1 Clinical Trial Data Showing Treatment With Flibanserin Results In No Next-Day Driving Impairment 3Alarming Stats Show Holiday Drinking an Issue for Many 2
... 10, 2011 BioDelivery Sciences International, Inc. (Nasdaq: ... initiated a confirmatory pharmacokinetic study of a formulation ... MucoAdhesive (BEMA) drug delivery technology.   ... BNX-102, will be used to select the final ...
... -- Korean Ministry of Health and Welfare (Minister Rim, ... Kyung-hwa) have announced that it would offer medical care ... the end of November through its 2011 Medical Charity ... South Korea,s advanced medical technology and services. ...
Cached Medicine Technology:BioDelivery Sciences Initiates Confirmatory Pharmacokinetic Study of BEMA Buprenorphine/Naloxone Compared to Suboxone 2BioDelivery Sciences Initiates Confirmatory Pharmacokinetic Study of BEMA Buprenorphine/Naloxone Compared to Suboxone 3BioDelivery Sciences Initiates Confirmatory Pharmacokinetic Study of BEMA Buprenorphine/Naloxone Compared to Suboxone 42011 Korea's Medical Charity Program offers care for 31 int'l child patients 2
(Date:11/24/2014)... SafeHandles™ announced that they will be featured in ... airing via Discovery Channel. Dates and show times TBA. ... replaceable, and affordable germ protective device. This segment will ... adhesives to promote hand hygiene in high traffic and ... is the desire to make a positive impact in ...
(Date:11/23/2014)... 24, 2014 The clinical trial ... provides data on the Aspergillosis clinical trial scenario. ... to the clinical trials on Aspergillosis. It includes ... recruitment status as per the site of trial ... preliminary coverage of disease clinical trials by their ...
(Date:11/23/2014)... Pro Ace Care, a renowned Vancouver hot water tank ... an 8 year warranty on its selected hot water tanks. ... due to the impending winter season, it was important for ... service that the company provides. As a result, Pro Ace ... and Bradford hot water tanks. , “Every installer who ...
(Date:11/23/2014)... (PRWEB) November 23, 2014 This ... such as its significance, programs and manufacturing technological ... Chinese suppliers major market gamers in information. In ... item specifications, prospective, manufacturing value, and 2009-2014 market ... the evaluation symbolizes the globally and Chinese suppliers ...
(Date:11/23/2014)... Asher Milgrom, is a celebrity doctor ... was recently featured on International Business Times. ... of American Medical Aesthetics & Wellness, also known as ... scholarship to attend an M.D./Ph.D program at University of ... of Chicago, where his field of study was neuro-biochemistry. ...
Breaking Medicine News(10 mins):Health News:New Episode of Innovations TV Series to Feature SafeHandles™ 2Health News:Aspergillosis Pipeline and Clinical Trials Market (Compnies and Drugs) Review H2 2014 Report at ReportsnReports.com 2Health News:Aspergillosis Pipeline and Clinical Trials Market (Compnies and Drugs) Review H2 2014 Report at ReportsnReports.com 3Health News:Aspergillosis Pipeline and Clinical Trials Market (Compnies and Drugs) Review H2 2014 Report at ReportsnReports.com 4Health News:Pro Ace Care Now Gives 8 Year Guarantee on Selected Vancouver Hot Water Tanks 2Health News:Femoral Stems Industry 2014 Analysis & 2019 Forecasts for Global and Chinese Region in New Research Report at ReportsnReports.com 2Health News:Femoral Stems Industry 2014 Analysis & 2019 Forecasts for Global and Chinese Region in New Research Report at ReportsnReports.com 3Health News:Femoral Stems Industry 2014 Analysis & 2019 Forecasts for Global and Chinese Region in New Research Report at ReportsnReports.com 4Health News:Asher Milgrom Is the Founding Doctor of AMA Skincare and Is Featured in the International Business Times 2Health News:Asher Milgrom Is the Founding Doctor of AMA Skincare and Is Featured in the International Business Times 3Health News:Asher Milgrom Is the Founding Doctor of AMA Skincare and Is Featured in the International Business Times 4
... to its increasing potential as a,tool in health ... attention from insurers and the media.,We,ve probably all ... data as,a predictor in the underwriting process. In ... perspective on an advance in risk,selection and classification ...
... BALTIMORE, June 3 A new website,( http://www.shofarcoalition.org ... and emotional abuse and neglect of Jewish children. ... specialized services,for children, adolescents, and adults who are ... Shofar Coalition is a Baltimore-based,group, the information on ...
... -- Global climate change will not only impact plants and ... populations that perform a myriad of functions important to life ... effects will be, but they could be significant and will ... meeting in Boston. , Microbes perform a number of critical ...
... June 3 To shed unwanted pounds,Americans, spend ... However,many doctors and dietitians say merely choosing the ... younger, decrease inflammation in our,bodies, and feel more ... to prepare,the healthy ingredients we,re encouraged to buy. ...
... Veterinary medicine contributes $3.3 billion to the economies ... as many as 658 veterinarians by 2014, according to ... Veterinary Medicine at Tufts University. , The ... the Cummings School, the only veterinary school in the ...
... Bally Personal Trainers For Peak ... Performance, LOS ANGELES, June ... Simpson and Cher, now the,Pussycat Dolls are working out with Bally. On the ... music video for,their hot new single "When I Grow Up," the Pussycat Dolls ...
Cached Medicine News:Health News:Milliman Announces Encore Webinar on Practical Uses of Lifestyle-Based Analytics (LBA) in Risk Selection 2Health News:New Program/Website Targets Jewish Children, Teens, and Adults Suffering from the Impact of Childhood Maltreatment 2Health News:Climate change could impact vital functions of microbes 2Health News:Climate change could impact vital functions of microbes 3Health News:Natural Solutions Names 45 Must-Have Foods for Healthy Weight Loss 2Health News:Veterinary medicine contributes $3.3 billion to New England economy 2Health News:Veterinary medicine contributes $3.3 billion to New England economy 3Health News:Veterinary medicine contributes $3.3 billion to New England economy 4Health News:Pussycat Dolls Shape Up With Bally Total Fitness 2
... III is an advanced Doppler system that ... throughout the body. This method of measurement ... arteries supplying blood to the brain. , ... neurological vascular problems such as vasospasm and ...
... forceps have very fine tips and are intended ... microscope is required. The curved ones are ideal ... metal shards. The student versions are for beginners. ... be static free. The Swiss forceps are made ...
Vertigraft femoral shaft an large femoral cross-section designed primarily for use in lumbar corpectomy procedures. Freeze dried preservation....
... Vitoss engineered to ... porosity and structure. -TCP ... well in spinal arthrodesis ... defects due to trauma ...
Medicine Products: